Table of Contents

1 Study Coverage

• 1.1 Contrast Injector Systems Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Contrast Injector Systems Market Size Growth Rate by Product
  • 1.4.2 Injector Systems
  • 1.4.3 Consumables
  • 1.4.4 Accessories
• 1.5 Market by End User
  • 1.5.1 Global Contrast Injector Systems Market Size Growth Rate by End User
  • 1.5.2 Diagnostics Centers
  • 1.5.3 Clinics
  • 1.5.4 Hospitals
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Contrast Injector Systems Market Size
  • 2.1.1 Global Contrast Injector Systems Revenue 2014-2025
  • 2.1.2 Global Contrast Injector Systems Sales 2014-2025
• 2.2 Contrast Injector Systems Growth Rate by Regions
  • 2.2.1 Global Contrast Injector Systems Sales by Regions
  • 2.2.2 Global Contrast Injector Systems Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Contrast Injector Systems Sales by Manufacturers
  • 3.1.1 Contrast Injector Systems Sales by Manufacturers
  • 3.1.2 Contrast Injector Systems Sales Market Share by Manufacturers
  • 3.1.3 Global Contrast Injector Systems Market Concentration Ratio (CR5 and HHI)
• 3.2 Contrast Injector Systems Revenue by Manufacturers
  • 3.2.1 Contrast Injector Systems Revenue by Manufacturers (2014-2019)
  • 3.2.2 Contrast Injector Systems Revenue Share by Manufacturers (2014-2019)
• 3.3 Contrast Injector Systems Price by Manufacturers
• 3.4 Contrast Injector Systems Manufacturing Base Distribution, Product Types
  • 3.4.1 Contrast Injector Systems Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Contrast Injector Systems Product Type
  • 3.4.3 Date of International Manufacturers Enter into Contrast Injector Systems Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Contrast Injector Systems Sales by Product
• 4.2 Global Contrast Injector Systems Revenue by Product
• 4.3 Contrast Injector Systems Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Contrast Injector Systems Breakdown Data by End User

6 North America

• 6.1 North America Contrast Injector Systems by Countries
  • 6.1.1 North America Contrast Injector Systems Sales by Countries
  • 6.1.2 North America Contrast Injector Systems Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Contrast Injector Systems by Product
• 6.3 North America Contrast Injector Systems by End User

7 Europe

• 7.1 Europe Contrast Injector Systems by Countries
  • 7.1.1 Europe Contrast Injector Systems Sales by Countries
  • 7.1.2 Europe Contrast Injector Systems Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Contrast Injector Systems by Product
• 7.3 Europe Contrast Injector Systems by End User

8 Asia Pacific

• 8.1 Asia Pacific Contrast Injector Systems by Countries
  • 8.1.1 Asia Pacific Contrast Injector Systems Sales by Countries
  • 8.1.2 Asia Pacific Contrast Injector Systems Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Contrast Injector Systems by Product
• 8.3 Asia Pacific Contrast Injector Systems by End User

9 Central & South America

• 9.1 Central & South America Contrast Injector Systems by Countries
  • 9.1.1 Central & South America Contrast Injector Systems Sales by Countries
  • 9.1.2 Central & South America Contrast Injector Systems Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Contrast Injector Systems by Product
• 9.3 Central & South America Contrast Injector Systems by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Contrast Injector Systems by Countries
  • 10.1.1 Middle East and Africa Contrast Injector Systems Sales by Countries
  • 10.1.2 Middle East and Africa Contrast Injector Systems Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Contrast Injector Systems by Product
• 10.3 Middle East and Africa Contrast Injector Systems by End User

11 Company Profiles

• 11.1 Bracco
  • 11.1.1 Bracco Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Bracco Contrast Injector Systems Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Bracco Contrast Injector Systems Products Offered
  • 11.1.5 Bracco Recent Development
• 11.2 Bayer AG
  • 11.2.1 Bayer AG Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Bayer AG Contrast Injector Systems Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Bayer AG Contrast Injector Systems Products Offered
  • 11.2.5 Bayer AG Recent Development
• 11.3 Guerbet Group
  • 11.3.1 Guerbet Group Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Guerbet Group Contrast Injector Systems Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Guerbet Group Contrast Injector Systems Products Offered
  • 11.3.5 Guerbet Group Recent Development
• 11.4 Medtron AG
  • 11.4.1 Medtron AG Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Medtron AG Contrast Injector Systems Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Medtron AG Contrast Injector Systems Products Offered
  • 11.4.5 Medtron AG Recent Development
• 11.5 Ulrich GmbH & Co. KG
  • 11.5.1 Ulrich GmbH & Co. KG Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Ulrich GmbH & Co. KG Contrast Injector Systems Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Ulrich GmbH & Co. KG Contrast Injector Systems Products Offered
  • 11.5.5 Ulrich GmbH & Co. KG Recent Development
• 11.6 GE Healthcare
  • 11.6.1 GE Healthcare Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 GE Healthcare Contrast Injector Systems Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 GE Healthcare Contrast Injector Systems Products Offered
  • 11.6.5 GE Healthcare Recent Development
• 11.7 Shenzhen Seacrown Electromechanical
  • 11.7.1 Shenzhen Seacrown Electromechanical Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Shenzhen Seacrown Electromechanical Contrast Injector Systems Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Shenzhen Seacrown Electromechanical Contrast Injector Systems Products Offered
  • 11.7.5 Shenzhen Seacrown Electromechanical Recent Development
• 11.8 Nemoto Kyorindo
  • 11.8.1 Nemoto Kyorindo Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Nemoto Kyorindo Contrast Injector Systems Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Nemoto Kyorindo Contrast Injector Systems Products Offered
  • 11.8.5 Nemoto Kyorindo Recent Development
• 11.9 Sino Medical- Device Technology
  • 11.9.1 Sino Medical- Device Technology Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Sino Medical- Device Technology Contrast Injector Systems Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Sino Medical- Device Technology Contrast Injector Systems Products Offered
  • 11.9.5 Sino Medical- Device Technology Recent Development
• 11.10 Vivid Imaging
  • 11.10.1 Vivid Imaging Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Vivid Imaging Contrast Injector Systems Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Vivid Imaging Contrast Injector Systems Products Offered
  • 11.10.5 Vivid Imaging Recent Development
• 11.11 Network Imaging Systems
• 11.12 IRadimed Corporation
• 11.13 Covidien
• 11.14 Agito Medical
• 11.15 Merit Medical Systems

12 Future Forecast

• 12.1 Contrast Injector Systems Market Forecast by Regions
  • 12.1.1 Global Contrast Injector Systems Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Contrast Injector Systems Revenue Forecast by Regions 2019-2025
• 12.2 Contrast Injector Systems Market Forecast by Product
  • 12.2.1 Global Contrast Injector Systems Sales Forecast by Product 2019-2025
  • 12.2.2 Global Contrast Injector Systems Revenue Forecast by Product 2019-2025
• 12.3 Contrast Injector Systems Market Forecast by End User
• 12.4 North America Contrast Injector Systems Forecast
• 12.5 Europe Contrast Injector Systems Forecast
• 12.6 Asia Pacific Contrast Injector Systems Forecast
• 12.7 Central & South America Contrast Injector Systems Forecast
• 12.8 Middle East and Africa Contrast Injector Systems Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Contrast Injector Systems Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Contrast injector systems are medical devices that use contrast media to enhance the visibility of complex body structures such as body fluids, tissues, arteries, and veins. The diagnosis is conducted with the help of many imaging procedures such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography.
The rise in geriatric population coupled with rapid rise in chronic diseases as well as the demand for early and minimal-invasive diagnosis are the key factors that drive the growth of the contrast injector systems market. However, the high cost of contrast injector systems and the risks associated with the use of contrast media in the injector system is projected to impede the market growth. Moreover, the increase in healthcare expenditure and the emergence of complex diseases in emerging economies are expected to create lucrative opportunities for key market players.
The global Contrast Injector Systems market is valued at 620 million US$ in 2018 and will reach 1140 million US$ by the end of 2025, growing at a CAGR of 7.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Contrast Injector Systems market based on company, product type, end user and key regions.

This report studies the global market size of Contrast Injector Systems in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Contrast Injector Systems in these regions.
This research report categorizes the global Contrast Injector Systems market by top players/brands, region, type and end user. This report also studies the global Contrast Injector Systems market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bracco
Bayer AG
Guerbet Group
Medtron AG
Ulrich GmbH & Co. KG
GE Healthcare
Shenzhen Seacrown Electromechanical
Nemoto Kyorindo
Sino Medical- Device Technology
Vivid Imaging
Network Imaging Systems
IRadimed Corporation
Covidien
Agito Medical
Merit Medical Systems

Market size by Product
Injector Systems
Consumables
Accessories
Market size by End User
Diagnostics Centers
Clinics
Hospitals
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Contrast Injector Systems market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Contrast Injector Systems market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Contrast Injector Systems companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Contrast Injector Systems submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Contrast Injector Systems are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Contrast Injector Systems market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.